Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

SEATTLE, June 25, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today issued the following statement regarding the notification of the U.S. Food and Drug Administration (the "FDA") partial clinical hold on tosedostat (IND 075503), the Company's aminopeptidase inhibitor under development for the treatment of blood-related cancers, that is being studied in an investigator-sponsored trial and not by CTI. CTI's primary development programs are the ongoing Phase 3 trial of pacritinib, the Company's JAK2/FLT3 inhibitor being evaluated for patients with myelofibrosis, and the post-approval commitment study of PIXUVRI® (pixantrone).

This is a partial clinical hold of only part of the clinical work requested under the investigational new drug ("IND") application. Under a partial clinical hold, although a specific protocol or part of a protocol is not allowed to proceed, other parts of such protocol or other protocols are allowed to proceed under the IND. With this partial clinical hold, the Company may not enter new patients onto any of the ongoing tosedostat protocols until agreement is reached with the FDA.

After a study has been placed on partial clinical hold, the sponsor provides additional information and discusses the adverse event with the FDA to understand whether or not it was associated with the drug or due to another cause. The Company has begun work to comply with the FDA request and expects to be able to submit these data to the FDA in the coming weeks. For additional information, please refer to the Current Report on Form 8-K filed by the Company on June 24, 2013.

Recent Tosedostat Publication
In March 2013, Lancet Oncology published results from the OPAL Phase 2 study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML). The trial showed that once-daily oral tosedostat resulted in a disease contro
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... KUALA LUMPUR, Malaysia , April 20, 2015 /PRNewswire/ ... 2015, resulting in a scarcity of opportunities for generic ... drug manufacturers in the region are looking beyond the ... the quality of existing drugs. Certain established generic manufacturers ... research and development of new molecules, although the impact ...
(Date:4/20/2015)... Dr. Gregory Taylor , Canada,s Chief ... after spending a week in West Africa . ... needs on the ground as global efforts continue to reach zero ... prevention efforts in Sierra Leone and ... first-hand the work being done and hear from those on the ...
(Date:4/20/2015)... 20, 2015 Actavis plc (NYSE: ... Mayr , Chief Communications Officer, will retire from ...  In conjunction with Mayr,s retirement, Alex Kelly ... of Chief Communications Officer, effective immediately. Prior to ... Vice President, Chief Communications Officer, Public Affairs and ...
Breaking Medicine Technology:Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 2Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 4Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 5Canada's Efforts Making a Difference in the Fight Against Ebola 2Canada's Efforts Making a Difference in the Fight Against Ebola 3Canada's Efforts Making a Difference in the Fight Against Ebola 4Canada's Efforts Making a Difference in the Fight Against Ebola 5Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3
(Date:4/21/2015)... Optimity Advisors ( Optimity), ... that helps clients in complex industries navigate rapid ... Association of Community Affiliated Plans (ACAP) ... 58 local, not-for-profit, community-affiliated Safety Net Health Plans ... primarily enrolled in public or state-sponsored coverage programs, ...
(Date:4/21/2015)... 2015 When a bandage sticks to ... In order to solve this problem two inventors from ... This improved bandage helps a cut, burn, abrasion or ... enhances air exposure. The bandage is easy to use, ... design was submitted to the St. Louis office of ...
(Date:4/21/2015)... April 21, 2015 NOVAtime Technology, ... enterprise Time and Attendance / Workforce Management solutions, ... from the American Payroll Association (APA) as well ... The APA has been the nation’s payroll authority ... networking opportunities, and recertification credits. Held at the ...
(Date:4/21/2015)... DC (PRWEB) April 21, 2015 ... announce the launch of Medicare-Medicaid Dual Eligibles Database, ... focuses on care provided to the more than ... who account for more than $300 billion in ... researchers – the same team that also creates ...
(Date:4/21/2015)... 2015 One of the most difficult ... meal food cravings. Many diets end badly due to ... meals. Some attempt to eat more often throughout the ... more regular intervals. While this approach does work for ... directly after a meal. For those who are having ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 2Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 3Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 3
... NEW YORK, June 24 Twinlab is proud to announce the ... J. Aaron Memorial Mighty Montauk Triathlon. With winners in most divisions, ... The race consisted of a 1 mile swim, 22 mile bike ... the team, Andrew Kalley placed second and for her first win, ...
... , WASHINGTON, June 24 Attorney General Eric Holder, Health and Human ... will announce a law enforcement action related to the Health Care Fraud ... WEDNESDAY, JUNE 24, at 12:30 P.M. ET. , ... Human Services Secretary Kathleen Sebelius , FBI Director Robert S. Mueller, ...
... LifeSculpt is minimally-invasive and offers a faster recovery ... Mass., June 24 ... developer for cosmetic treatments, announced today the nationwide ... LifeSculpt features the SlimLipo laser body sculpting technology, ...
... and largest provider of retail health care in the ... provider in all insurance plans offered by CareFirst BlueCross ... CareFirst is the largest health care insurer in ... a participating provider with CareFirst,s preferred provider and federal ...
... , SALT LAKE CITY, June 24 Dynatronics Corporation ... shipping its new V-Force Vibration Therapy units to customers. ... provides neuromuscular training to increase strength, improve balance and ... Russian space program to compensate for bone and muscle ...
... , HARRISBURG, Pa., June 24 According to the ... Of that number, unfortunately, 5.7 million people are unaware ... parts of the body, including the kidneys, nerves, heart ... diabetics are more prone to several oral health problems, ...
Cached Medicine News:Health News:Team Full Throttle Twinlab(R) Racing Nabs Podiums in Several Divisions at the 2009 Robert J. Aaron Memorial Mighty Montauk Triathlon 2Health News:Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment 2Health News:Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment 3Health News:Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment 4Health News:MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 2Health News:MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 3Health News:Dynatronics Begins Shipping New V-Force Vibration Therapy Units 2Health News:Dynatronics Begins Shipping New V-Force Vibration Therapy Units 3Health News:Diabetes: It's Connection to Oral Health 2Health News:Diabetes: It's Connection to Oral Health 3
Latex agglutination slide test for the qualitative and semi-qualitative detection of antinuclear antibodies to aid in the diagnosis of systemic lupus erthyematosus....
Color-enhanced slide test for the rapid qualitative and semi-quantitative detection of antibodies to streptococcal extracellular antigens in serum, plasma and peripheral blood....
Latex agglutination slide test to aid in the identification of Staphylococcus aureus colonies from culture media....
Hemagglutination slide test for the qualitative and quantitative detection of Rheumatoid Factor in serum or synovial fluid....
Medicine Products: